Within this concentration range, DGLA appeared to induce apoptosis in ovarian cancer cells as shown by an increase in PARP and caspase 3 cleavage and upregulated DR5 expression, which helps to explain mechanism of reporter DGLA anticancer activity in multiple cancers. The gene discussed is TNFRSF10B; the disease is ovarian carcinoma.